Neurobiology of schizophrenia
- PMID: 9384552
- DOI: 10.1016/s0959-4388(97)80092-x
Neurobiology of schizophrenia
Abstract
Schizophrenia appears to be a neurodevelopmental disorder involving dysfunctional prefrontal and temporal cortical neural systems. Recent data implicate presynaptic changes in subcortical dopamine neurotransmission, as well as alterations in cortical glutamatergic and GABAergic systems. Functional neuroimaging studies, combined with tests of neuropsychological function, suggest that cortical abnormalities underlie the cognitive deficits associated with schizophrenia. These deficits appear to account for much of the psychosocial dysfunction of schizophrenia and are particularly treatment refractory. Genetic studies have implicated several minor susceptibility loci; however, the clinical impact of these loci on the neurobiology of schizophrenia is still unclear. The use of neurobiological traits as phenotypes, such as cognitive deficits and cortical abnormalities, in genetic linkage studies may facilitate the identification of loci that underlie the most debilitating features of schizophrenia.
Similar articles
-
Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.Int Rev Neurobiol. 2007;78:69-108. doi: 10.1016/S0074-7742(06)78003-5. Int Rev Neurobiol. 2007. PMID: 17349858 Review.
-
Molecular brain imaging and the neurobiology and genetics of schizophrenia.Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S152-7. doi: 10.1055/s-2003-45123. Pharmacopsychiatry. 2003. PMID: 14677072 Review.
-
Synaptic dysfunction in schizophrenia.Adv Exp Med Biol. 2012;970:493-516. doi: 10.1007/978-3-7091-0932-8_22. Adv Exp Med Biol. 2012. PMID: 22351070 Review.
-
Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities.Schizophr Res. 2004 Aug 1;69(2-3):237-53. doi: 10.1016/j.schres.2003.09.017. Schizophr Res. 2004. PMID: 15469196 Review.
-
Neurobiological background of negative symptoms.Eur Arch Psychiatry Clin Neurosci. 2015 Oct;265(7):543-58. doi: 10.1007/s00406-015-0590-4. Epub 2015 Mar 24. Eur Arch Psychiatry Clin Neurosci. 2015. PMID: 25797499 Review.
Cited by
-
The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats.Psychopharmacology (Berl). 2005 Jan;177(3):264-71. doi: 10.1007/s00213-004-1941-4. Epub 2004 Jul 28. Psychopharmacology (Berl). 2005. PMID: 15290008
-
Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability.Arch Gen Psychiatry. 2009 May;66(5):467-77. doi: 10.1001/archgenpsychiatry.2009.24. Arch Gen Psychiatry. 2009. PMID: 19414706 Free PMC article.
-
Subchronic oral administration of crude khat extract (Catha edulis forsk) induces schizophernic-like symptoms in mice.BMC Complement Altern Med. 2016 May 31;16:153. doi: 10.1186/s12906-016-1145-6. BMC Complement Altern Med. 2016. PMID: 27245332 Free PMC article.
-
Smoking behaviour and mental health disorders--mutual influences and implications for therapy.Int J Environ Res Public Health. 2013 Oct 10;10(10):4790-811. doi: 10.3390/ijerph10104790. Int J Environ Res Public Health. 2013. PMID: 24157506 Free PMC article. Review.
-
Exosomal secretion of a psychosis-altered miRNA that regulates glutamate receptor expression is affected by antipsychotics.Neuropsychopharmacology. 2020 Mar;45(4):656-665. doi: 10.1038/s41386-019-0579-1. Epub 2019 Nov 27. Neuropsychopharmacology. 2020. PMID: 31775160 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical